USP Sounds Alarm As Delta-8 THC Noise Grows Louder In US Hemp Ingredients Market
On same day USP published report on delta-8 THC, former FDA executive who led a marijuana policy working group while there advised that banishing the ingredient won’t come any easier than controlling the use of hemp ingredients in non-drug products subject to the agency’s regulatory oversight.
You may also be interested in...
Announcement and warnings, in addition to noting firms’ violative drug and disease claims, explain differences between delta-8 THC and other hemp-derived cannabinoids intended for de-scheduling as controlled substances in 2018 farm bill.
Delta-8 THC is a close chemical cousin to the substance recognized for intoxicating effects. Its effects aren't a settled question, along with whether it meets definition of hemp stated in 2018 farm bill.
FDA’s “Additional Condition for Nonprescription Use” proposal is all about information which won’t be printed on DFLs but will be integral to whether some switch proposals’ approval. But agency doesn’t explicitly exclude switch sponsors from assigning delivery of ACNU information to staff in stores or in online chats.